Related Experiment Videos
Candida Pericarditis in a patients with leukaemia
Scandinavian Journal of Haematology
|August 1, 1981
Summary
This case report details the first successful clinical diagnosis and treatment of candidal pericarditis in a patient with acute lymphoblastic leukemia. Antifungal therapy with amphotericin B, flucytosine, and miconazole effectively cleared Candida albicans from blood and pericardial fluid.
Area of Science:
- Infectious Diseases
- Cardiology
- Hematology
Background:
- Candidal pericarditis is an exceptionally rare fungal infection affecting the pericardium.
- Diagnosis and successful treatment of this condition are infrequently documented in medical literature.
- Acute lymphoblastic leukemia (ALL) is a hematologic malignancy that can predispose patients to opportunistic infections.
Observation:
- A 30-year-old male diagnosed with acute lymphoblastic leukemia presented with exudative pleuropericarditis.
- Persistent fever and positive blood and pericardial fluid cultures confirmed a diagnosis of Candida albicans infection.
- The patient exhibited clinical signs suggestive of a leukaemic origin for the initial pleuropericarditis.
Findings:
- Intravenous treatment with amphotericin B, flucytosine, and miconazole for three weeks resulted in the sterilization of blood and pericardial fluid.
- Therapeutic drug monitoring confirmed adequate amphotericin B levels in the pericardial fluid without the need for local instillation.
- This regimen demonstrated efficacy in eradicating Candida albicans from the pericardial space.
Implications:
- This case highlights the possibility of diagnosing and successfully treating invasive candidal pericarditis, even in immunocompromised patients.
- The findings support the use of systemic antifungal therapy for candidal pericarditis, achieving therapeutic concentrations in the pericardial fluid.
- This report contributes valuable clinical data for managing rare fungal infections in leukemia patients, guiding future therapeutic strategies.